UY26440A1 - Método para aliviar la ansiedad - Google Patents
Método para aliviar la ansiedadInfo
- Publication number
- UY26440A1 UY26440A1 UY26440A UY26440A UY26440A1 UY 26440 A1 UY26440 A1 UY 26440A1 UY 26440 A UY26440 A UY 26440A UY 26440 A UY26440 A UY 26440A UY 26440 A1 UY26440 A1 UY 26440A1
- Authority
- UY
- Uruguay
- Prior art keywords
- relieve anxiety
- anxiety
- relieve
- azaspiro
- dione
- Prior art date
Links
- 208000019901 Anxiety disease Diseases 0.000 title abstract 2
- 230000036506 anxiety Effects 0.000 title abstract 2
- -1 4- (4- (2-pyrimidinyl) - piperazinyl) -butyl Chemical group 0.000 abstract 1
- 150000004677 hydrates Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
Abstract
La 6-hidroxi-8-(4-(4-(2-pirimidinil)- piperazinil) -butil) -8- azaspiro (4.5)-7,9-diona y sus sales e hidratos farmacéuticamente aceptables, son útiles en el alivio de la ansiedad.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US48416100A | 2000-01-18 | 2000-01-18 | |
US09/588,221 US6150365A (en) | 1999-08-05 | 2000-06-06 | Anxiety method |
Publications (1)
Publication Number | Publication Date |
---|---|
UY26440A1 true UY26440A1 (es) | 2001-08-27 |
Family
ID=27047894
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY26440A UY26440A1 (es) | 2000-01-18 | 2000-11-16 | Método para aliviar la ansiedad |
Country Status (22)
Country | Link |
---|---|
US (1) | US6150365A (es) |
EP (1) | EP1248622B1 (es) |
JP (1) | JP2003520236A (es) |
KR (1) | KR20020073176A (es) |
CN (1) | CN1424911A (es) |
AR (1) | AR028201A1 (es) |
AT (1) | ATE300302T1 (es) |
AU (1) | AU775591B2 (es) |
BR (1) | BR0016971A (es) |
CA (1) | CA2406732A1 (es) |
CZ (1) | CZ20022461A3 (es) |
DE (1) | DE60021609D1 (es) |
HU (1) | HUP0204285A3 (es) |
IL (1) | IL150019A0 (es) |
MX (1) | MXPA02007003A (es) |
NO (1) | NO20023425L (es) |
NZ (1) | NZ520823A (es) |
PL (1) | PL355966A1 (es) |
RU (1) | RU2254132C2 (es) |
TW (1) | TWI226831B (es) |
UY (1) | UY26440A1 (es) |
WO (1) | WO2001052853A1 (es) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050137206A1 (en) * | 1999-08-05 | 2005-06-23 | Yevich Joseph P. | Method for treatment of anxiety and depression |
US20030069251A1 (en) * | 1999-08-05 | 2003-04-10 | Yevich Joseph P. | Antianxiety composition |
US6150365A (en) * | 1999-08-05 | 2000-11-21 | Bristol-Myers Squibb Company | Anxiety method |
WO2002077168A2 (en) * | 2001-03-22 | 2002-10-03 | Merck & Co., Inc. | Mch1r deficient mice |
US6593331B2 (en) | 2001-04-17 | 2003-07-15 | Laboratories Upsa | Method for treatment of pain |
EP1417203A4 (en) * | 2001-07-24 | 2005-08-10 | Bristol Myers Squibb Co | S-6-HYDROXY-BUSPIRONE |
EP1408979A4 (en) | 2001-07-24 | 2005-03-23 | Bristol Myers Squibb Co | R-6-HYDROXY-BUSPIRONE |
EP1542689A2 (en) * | 2002-08-12 | 2005-06-22 | Bristol-Myers Squibb Company | Improved process for hydroxyazapirones |
US20040147581A1 (en) * | 2002-11-18 | 2004-07-29 | Pharmacia Corporation | Method of using a Cox-2 inhibitor and a 5-HT1A receptor modulator as a combination therapy |
CA2514574A1 (en) * | 2003-01-30 | 2004-08-12 | Dynogen Pharmaceuticals, Inc. | Use of sodium channel modulators for treating gastrointestinal tract disorders |
RU2611376C2 (ru) | 2010-10-15 | 2017-02-21 | Контера Фарма Апс | Фармацевтическая композиция для лечения, профилактики или облегчения двигательных расстройств и ее применение |
HUE037732T2 (hu) | 2012-04-18 | 2018-09-28 | Contera Pharma Aps | A mozgászavarok fejlett kezelésére alkalmas, szájon át szedhetõ gyógyszerészeti készítmény |
HUE039750T2 (hu) | 2014-06-26 | 2019-02-28 | Contera Pharma Aps | Hidroxi-buspiron mozgászavarok kezelésére |
WO2018011181A1 (en) | 2016-07-11 | 2018-01-18 | Contera Pharma Aps | Pulsatile drug delivery system for treating morning akinesia |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE759371A (fr) * | 1969-11-24 | 1971-05-24 | Bristol Myers Co | Azaspirodecanediones heterocycliques et procedes pour leur preparation |
US4182763A (en) * | 1978-05-22 | 1980-01-08 | Mead Johnson & Company | Buspirone anti-anxiety method |
US4409223A (en) * | 1982-08-06 | 1983-10-11 | Riblet Leslie A | Anxiolytic method |
US5633009A (en) * | 1990-11-28 | 1997-05-27 | Sano Corporation | Transdermal administration of azapirones |
US5431922A (en) * | 1991-03-05 | 1995-07-11 | Bristol-Myers Squibb Company | Method for administration of buspirone |
AU5101798A (en) * | 1996-12-04 | 1998-06-29 | Bristol-Myers Squibb Company | Method for oral administration of buspirone |
US6150365A (en) * | 1999-08-05 | 2000-11-21 | Bristol-Myers Squibb Company | Anxiety method |
-
2000
- 2000-06-06 US US09/588,221 patent/US6150365A/en not_active Expired - Fee Related
- 2000-10-18 RU RU2002118304/14A patent/RU2254132C2/ru not_active IP Right Cessation
- 2000-10-18 KR KR1020027009260A patent/KR20020073176A/ko not_active Application Discontinuation
- 2000-10-18 BR BR0016971-4A patent/BR0016971A/pt not_active IP Right Cessation
- 2000-10-18 NZ NZ520823A patent/NZ520823A/en unknown
- 2000-10-18 WO PCT/US2000/028800 patent/WO2001052853A1/en active IP Right Grant
- 2000-10-18 MX MXPA02007003A patent/MXPA02007003A/es unknown
- 2000-10-18 CA CA002406732A patent/CA2406732A1/en not_active Abandoned
- 2000-10-18 IL IL15001900A patent/IL150019A0/xx unknown
- 2000-10-18 HU HU0204285A patent/HUP0204285A3/hu unknown
- 2000-10-18 AT AT00973636T patent/ATE300302T1/de not_active IP Right Cessation
- 2000-10-18 DE DE60021609T patent/DE60021609D1/de not_active Expired - Lifetime
- 2000-10-18 CN CN00818472A patent/CN1424911A/zh active Pending
- 2000-10-18 AU AU12130/01A patent/AU775591B2/en not_active Ceased
- 2000-10-18 PL PL00355966A patent/PL355966A1/xx not_active Application Discontinuation
- 2000-10-18 CZ CZ20022461A patent/CZ20022461A3/cs unknown
- 2000-10-18 EP EP00973636A patent/EP1248622B1/en not_active Expired - Lifetime
- 2000-10-18 JP JP2001552900A patent/JP2003520236A/ja active Pending
- 2000-11-13 TW TW089124000A patent/TWI226831B/zh active
- 2000-11-16 UY UY26440A patent/UY26440A1/es not_active Application Discontinuation
-
2001
- 2001-01-18 AR ARP010100231A patent/AR028201A1/es unknown
-
2002
- 2002-07-17 NO NO20023425A patent/NO20023425L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
US6150365A (en) | 2000-11-21 |
WO2001052853A1 (en) | 2001-07-26 |
NO20023425D0 (no) | 2002-07-17 |
RU2002118304A (ru) | 2004-01-10 |
ATE300302T1 (de) | 2005-08-15 |
MXPA02007003A (es) | 2003-01-28 |
EP1248622A4 (en) | 2004-02-04 |
NO20023425L (no) | 2002-09-05 |
BR0016971A (pt) | 2002-10-15 |
NZ520823A (en) | 2004-05-28 |
AR028201A1 (es) | 2003-04-30 |
EP1248622B1 (en) | 2005-07-27 |
HUP0204285A2 (en) | 2003-05-28 |
HUP0204285A3 (en) | 2004-07-28 |
JP2003520236A (ja) | 2003-07-02 |
DE60021609D1 (de) | 2005-09-01 |
CN1424911A (zh) | 2003-06-18 |
IL150019A0 (en) | 2002-12-01 |
EP1248622A1 (en) | 2002-10-16 |
KR20020073176A (ko) | 2002-09-19 |
AU775591B2 (en) | 2004-08-05 |
AU1213001A (en) | 2001-07-31 |
CZ20022461A3 (cs) | 2003-09-17 |
CA2406732A1 (en) | 2001-07-26 |
TWI226831B (en) | 2005-01-21 |
PL355966A1 (en) | 2004-05-31 |
RU2254132C2 (ru) | 2005-06-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY26440A1 (es) | Método para aliviar la ansiedad | |
EA200300595A1 (ru) | Соединения пиперазинилпиразинов в качестве антагонистов серотонин 5-ht2 рецептора | |
HRP20080664A2 (en) | Substituted pyridine herbicides | |
ECSP045081A (es) | Derivados de 1,8-naftiridina y su uso para el tratamiento de la diabetes y trastornos relacionados | |
AR023777A1 (es) | Nuevos compuestos | |
ES2319886T3 (es) | Compuestos azabiciclicos condensados que inhiben el sutipo 1 del receptor valinoide (vr1). | |
SV2003000633A (es) | Nuevos tiadiazoles y oxadiazoles y su uso como inhibidores de fosfodiesterasa-7 | |
RS51271B (sr) | Čvrsta farmaceutska kompozicija koja sadrži donepezil hidrohlorid | |
RS53428B (en) | COMPOSITIONS AND ANTI-VIRUS ACTIVITY OF SUBSTITUTED AZAINDOLOXOSCETER PIPERAZINE DERIVATIVES | |
DE60100620D1 (de) | Gezielte elektrochemische reduktion von halogenierten 4-amino-picolinsäuren | |
ATE426603T1 (de) | Acyl- und sulfonylderivative 6,9- disubstitutierter 2-(trans-1,4-diaminocyclohexyl)-purine und ihre verwendung als antiproliferative mittel | |
TR200400645T4 (tr) | İkameli Fenil Piperazin türevleri, Bunların Hazırlanması ve kullanımları | |
ECSP034531A (es) | Derivados sustituidos de c-ciclohexilmetilamina | |
UY28007A1 (es) | Tratamiento terapeutico | |
BR0317708A (pt) | Composto, composição farmacêutica, e, uso de um composto | |
DE602005005024D1 (de) | Substituierte thieno- und thiazoloä2,3-düpyrimidine und ä2,3-cüpyridine als inhibitoren von tie2 | |
AR028772A1 (es) | 5-aminoalquil-pirazol[4,3-d] pirimidinas | |
MA28811B1 (fr) | Nouvelles utilisations de derives d'imidazotriazinones substituees par 2-phenyle | |
ATE355265T1 (de) | Biphenylcarboxamidderivate und ihre verwendung als p38 kinase inhibitoren | |
ATE481971T1 (de) | Formulierung von 3-amino-8-(1-piperazinyl)-2h- 1benzopyran-2-on mit verzögerter freisetzung | |
PE20020769A1 (es) | Forma de dosificacion oral para la administracion de la combinacion de tegafur, uracilo y acido folinico, y oxaliplatino y metodo de uso de los mismos | |
ECSP003767A (es) | Metodo para aliviar la ansiedad | |
TR200202439T2 (tr) | Sodyum hidrojen değiştirici tip 1 önleyici (NHE-1) | |
NO20030811L (no) | Kromenonderivater og anvendelse derav til behandling av sykdommer i forbindelse med 5-HTA1-reseptorer og/eller dopamin-D2-reseptorer | |
ES2185605T3 (es) | 2,3-dihidro-1h-5,9-dioxaciclohepta (f) inden-7-onas 1,2-sustituidas y benzo (b) (1,4)dioxepin-3 onas 7-sustituidas. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
109 | Application deemed to be withdrawn |
Effective date: 20120530 |